0000000000076363

AUTHOR

Elisa Brietzke

showing 6 related works from this author

Development and implementation of guidelines for the management of depression: a systematic review

2020

To evaluate the development and implementation of clinical practice guidelines for the management of depression globally.We conducted a systematic review of existing guidelines for the management of depression in adults with major depressive or bipolar disorder. For each identified guideline, we assessed compliance with measures of guideline development quality (such as transparency in guideline development processes and funding, multidisciplinary author group composition, systematic review of comparative efficacy research) and implementation (such as quality indicators). We compared guidelines from low- and middle-income countries with those from high-income countries.We identified 82 nati…

Adultmedicine.medical_specialtySystematic Reviewsmedia_common.quotation_subject030231 tropical medicine03 medical and health sciences0302 clinical medicineMultidisciplinary approachmedicineHumansGuideline developmentQuality (business)media_commonDepressive Disorder MajorDepressionbusiness.industryPublic Health Environmental and Occupational HealthEfficacy researchfeasibility studyGuidelineGuideline implementationFamily medicineTransparency (graphic)health impactbusinessguidelineManagement of depressionnervous system disorder
researchProduct

The potential use of biomarkers as an adjunctive tool for staging bipolar disorder

2009

Recent data show that biomarkers differ in early and late-stage bipolar disorder (BD). Here we propose a model of staging for bipolar disorder that emphasizes the potential use of biomarkers for differentiating early and late-stage BD patients in the inter-episodic period. The proposed model includes a Latent phase: patients at "ultra-high-risk" for developing BD, characterized by a family history of BD, temperament traits, mood, and anxiety symptoms as well as genetic vulnerability for developing the disorder; Stage I: patients who return to their baseline level of functioning when mood episodes resolve; Stage II: biomarkers and functioning impairment are related to comorbidities or rapid-…

Bipolar Disordermedia_common.quotation_subjectAnxietyModels BiologicalRisk FactorsmedicineHumansNerve Growth FactorsBipolar disorderFamily historyTemperamentBiological Psychiatrymedia_commonPharmacologyCognitive disorderCognitionmedicine.diseaseAffectMoodDisease ProgressionCytokinesAnxietyTemperamentmedicine.symptomCognition DisordersPsychologyManiaBiomarkersClinical psychologyProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments.

2018

Abstract Despite significant advances in pharmacological and non-pharmacological treatments, mood disorders remain a significant source of mental capital loss, with high rates of treatment resistance, requiring a coordinated effort in investigation and development of efficient, tolerable and accessible novel interventions. Ketogenic diet (KD) is a low-carb diet that substantially changes the energetic matrix of the body including the brain. It has been established as an effective anticonvulsant treatment, and more recently, the role of KD for mental disorders has been explored. Ketogenic diet has profound effects in multiple targets implicated in the pathophysiology of mood disorders, inclu…

business.industryMood DisordersCognitive Neurosciencemedicine.medical_treatmentPsychological interventionBioinformaticsmedicine.disease030227 psychiatry03 medical and health sciencesBehavioral Neuroscience0302 clinical medicineNeuropsychology and Physiological PsychologyAnticonvulsantMoodMood disordersmedicineAntidepressantAnimalsHumansBipolar disorderMetabolic syndromebusinessDiet Ketogenic030217 neurology & neurosurgeryKetogenic dietNeuroscience and biobehavioral reviews
researchProduct

Pre-training inter-rater reliability of clinical instruments in an international psychosis research project.

2021

International audience

Research designPsychosisINFORMATIONIMPACTApplied psychologyMEDLINEAssessor selection Pre-training inter-rater reliability Psychosis instruments03 medical and health sciences0302 clinical medicineMedicineHumansBiological PsychiatryComputingMilieux_MISCELLANEOUSObserver VariationREPRODUTIBILIDADE DE RESULTADOSbusiness.industryPre-training inter-rater reliabilityReproducibility of Resultsmedicine.disease030227 psychiatryPsychiatry and Mental healthInter-rater reliabilityAssessor selectionTRIALSPsychotic DisordersResearch Design[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]MEASUREMENT ERRORbusinessObserver variation030217 neurology & neurosurgeryPsychosis instrumentsSchizophrenia research
researchProduct

Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (I…

2021

Objectives Clinical staging is widely used in medicine to map disease progression, inform prognosis and guide treatment decisions; in psychiatry, however, staging remains a hypothetical construct. To facilitate future research in bipolar disorders (BD), a well-defined nomenclature is needed, especially since diagnosis is often imprecise with blurred boundaries, and a full understanding of pathophysiology is lacking. Methods Under the auspices of the International Society of Bipolar Disorders, a Task Force of international experts was convened to review, discuss, and integrate findings from the scientific literature relevant to the development of a consensus staging model and standardize a t…

medicine.medical_specialtyBipolar DisorderConsensusHeterogeneous groupTask forceAdvisory CommitteesDisease progressionScientific literaturePrognosisInternational Standard Bibliographic Descriptionmedicine.diseaseTerminologyPsychiatry and Mental healthSDG 3 - Good Health and Well-beingDisease ProgressionmedicineHumansNarrative reviewMedical physicsBipolar disorderPsychologyBiological PsychiatryBipolar Disorders
researchProduct

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

2014

European Community Recent years have seen considerable progress in epidemiological and molecular genetic research into environmental and genetic factors in schizophrenia, but methodological uncertainties remain with regard to validating environmental exposures, and the population risk conferred by individual molecular genetic variants is small. There are now also a limited number of studies that have investigated molecular genetic candidate gene-environment interactions (G x E), however, so far, thorough replication of findings is rare and G x E research still faces several conceptual and methodological challenges. in this article, we aim to review these recent developments and illustrate h…

URBANICITYSchizophrenia (object-oriented programming)CHILDHOODGenome-wide association studyVARIANTSSocial Environmentpsychosi03 medical and health sciences0302 clinical medicinePSYCHOSISepidemiology; gene-environment interaction; genetics; psychosis; schizophreniaSDG 3 - Good Health and Well-beingRISK-FACTORSettore M-PSI/08 - Psicologia ClinicaGenetic variationHumansGenetic Predisposition to DiseasegeneticspsychosisGENOME-WIDE ASSOCIATIONGeneSettore MED/25 - PsichiatriaMETAANALYSISScale (chemistry)schizophrenia; gene-environment interaction; Psychosis; epidemiology; geneticsGenetic variantsEnvironment and Schizophrenia InvitedCANNABIS USE3. Good health030227 psychiatrygene-environment interactionschizophreniaPsychiatry and Mental healthEvolutionary biology/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingIdentification (biology)Schizophrenic PsychologyepidemiologyPopulation RiskgeneticPsychologyFOLLOW-UP030217 neurology & neurosurgeryFUTURE-DIRECTIONSClinical psychology
researchProduct